![Pamela Wapnick](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pamela Wapnick
Director of Finance/CFO at
METAGENOMI THERAPEUTICS, INC.
Net worth: 283 548 $ as of 31/05/2026
Profile
Pamela Wapnick is currently Chief Financial Officer at Metagenomi Therapeutics, Inc. since 2023.
Former roles include Chief Financial Officer at Diality, Inc. from 2022 to 2023, Chief Financial Officer at Capsida Biotherapeutics, Inc. from 2019 to 2022, Chief Financial Officer at Graybug Vision, Inc. from 2017 to 2019, Vice President-Finance at Amgen, Inc. in 2016, and Chief Financial Officer positions at True North Therapeutics, Inc. and Metagenomi Technologies LLC.
Education includes undergraduate studies at Wellesley College and an MBA from Columbia Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 05/06/2026 | 208,491 ( 0.55% ) | 283 548 $ | 31/05/2026 |
Pamela Wapnick active positions
| Companies | Position | Start |
|---|---|---|
| METAGENOMI THERAPEUTICS, INC. | Director of Finance/CFO | 01/09/2023 |
Former positions of Pamela Wapnick
| Companies | Position | End |
|---|---|---|
Diality, Inc.
 Diality, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices | Director of Finance/CFO | 01/09/2023 |
Capsida Biotherapeutics, Inc.
 Capsida Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in the development of gene therapies for life threatening genetic disorders | Director of Finance/CFO | 01/06/2022 |
| CALCIMEDICA, INC. | Director of Finance/CFO | 01/10/2019 |
| AMGEN INC. | Director of Finance/CFO | 01/03/2016 |
True North Therapeutics, Inc.
 True North Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies that selectively inhibit the complement system to treat rare diseases | Director of Finance/CFO | - |
Training of Pamela Wapnick
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
60
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Graybug Vision, Inc.
 Graybug Vision, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company, which focuses on developing transformative medicines for the treatment of chronic diseases of retina and optic nerve | Health Technology |
Wellesley College
 Wellesley College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
True North Therapeutics, Inc.
True North Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies that selectively inhibit the complement system to treat rare diseases | Health Technology |
Metagenomi Technologies LLC
 Metagenomi Technologies LLC BiotechnologyHealth Technology Develops genetic medicines using metagenomics-powered genome editing toolbox | Health Technology |
Diality, Inc.
Diality, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices | Health Technology |
Capsida Biotherapeutics, Inc.
Capsida Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in the development of gene therapies for life threatening genetic disorders | Health Technology |
Metagenomi, Inc.
 Metagenomi, Inc. Pharmaceuticals: MajorHealth Technology Operates as a genetic medicines company that develops curative therapeutics for patients | Health Technology |
- Stock Market
- Insiders
- Pamela Wapnick
Choose MarketScreener 
